MBX Biosciences, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 224.94% | -- | -- | 65.60% | |
| Total Receivables | 227.88% | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 49.18% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 503.76% | -- | -- | -- | |
| Total Current Assets | 220.24% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 220.24% | -- | -- | -- | |
| Net Property, Plant & Equipment | 80.30% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.00% | -- | -- | -- | |
| Total Assets | 219.00% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 283.54% | -- | -- | -- | |
| Total Accrued Expenses | 132.79% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 11.76% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 181.48% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 181.48% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -78.35% | -- | -- | -- | |
| Total Liabilities | 158.52% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 12,826.09% | -- | -- | -- | |
| Retained Earnings | -81.93% | -- | -- | -- | |
| Treasury Stock & Other | -8.33% | -- | -- | -- | |
| Total Common Equity | 455.25% | -- | -- | -94.92% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 81.64% | |
|
|
|||||
| Total Common Equity | 455.25% | -- | -- | -94.92% | |
| Total Preferred Equity | -- | -- | -- | 81.64% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 222.25% | -- | -- | 67.93% | |
|
|
|||||